Martin J. Joyce, chief financial officer of Biosphere Medical, Inc. (NASDAQ: BSMD), a medical device company devoted to embolotherapy – a minimally invasive procedure performed primarily by interventional radiologists and neuroradiologists to treat hypervascularized tumors and arteriovenous malformations - recently presented at the Capstone Investment’s second-annual Small-Cap Investor Conference in Milwaukee, Wisconsin.